Veracyte Inc’s recent filing unveils that its VP, Chief Accounting Officer Wygant Jonathan unloaded Company’s shares for reported $0.23 million on Nov 07 ’25. In the deal valued at $40.21 per share,5,818 shares were sold. As a result of this transaction, Wygant Jonathan now holds 43,847 shares worth roughly $1.72 million.
Then, Wygant Jonathan sold 5,102 shares, generating $215,978 in total proceeds. Upon selling the shares at $42.33, the VP, Chief Accounting Officer now owns 38,745 shares.
Before that, McGuire Annie sold 6,466 shares. Veracyte Inc shares valued at $258,640 were divested by the SVP, General Counsel at a price of $40.00 per share. As a result of the transaction, McGuire Annie now holds 82,973 shares, worth roughly $3.26 million.
Canaccord Genuity initiated its Veracyte Inc [VCYT] rating to a Hold in a research note published on October 20, 2025; the price target was $40. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. Goldman also remained covering VCYT and has decreased its forecast on December 05, 2024 with a “Neutral” recommendation from previously “Buy” rating. Wolfe Research started covering the stock on November 15, 2024. It rated VCYT as “an Outperform”.
Price Performance Review of VCYT
On Monday, Veracyte Inc [NASDAQ:VCYT] saw its stock fall -0.18% to $39.28. Over the last five days, the stock has lost -7.25%. Veracyte Inc shares have fallen nearly -0.63% since the year began. Nevertheless, the stocks have fallen -0.81% over the past one year. While a 52-week high of $47.32 was reached on 01/30/25, a 52-week low of $22.61 was recorded on 07/18/25.
Levels Of Support And Resistance For VCYT Stock
The 24-hour chart illustrates a support level at 38.70, which if violated will result in even more drops to 38.13. On the upside, there is a resistance level at 39.84. A further resistance level may holdings at 40.41.
How much short interest is there in Veracyte Inc?
A steep rise in short interest was recorded in Veracyte Inc stocks on 2025-10-31, dropping by -1.29 million shares to a total of 6.04 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 7.33 million shares. There was a decline of -21.3%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 16, 2024 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $43 price target.
